1. Home
  2. CTSO vs CPBI Comparison

CTSO vs CPBI Comparison

Compare CTSO & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • CPBI
  • Stock Information
  • Founded
  • CTSO 1997
  • CPBI 2023
  • Country
  • CTSO United States
  • CPBI United States
  • Employees
  • CTSO N/A
  • CPBI N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • CPBI
  • Sector
  • CTSO Health Care
  • CPBI
  • Exchange
  • CTSO Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • CTSO 52.6M
  • CPBI 56.9M
  • IPO Year
  • CTSO N/A
  • CPBI N/A
  • Fundamental
  • Price
  • CTSO $1.18
  • CPBI $15.05
  • Analyst Decision
  • CTSO Buy
  • CPBI
  • Analyst Count
  • CTSO 2
  • CPBI 0
  • Target Price
  • CTSO $5.50
  • CPBI N/A
  • AVG Volume (30 Days)
  • CTSO 99.9K
  • CPBI 4.2K
  • Earning Date
  • CTSO 08-12-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • CTSO N/A
  • CPBI N/A
  • EPS Growth
  • CTSO N/A
  • CPBI 29.70
  • EPS
  • CTSO N/A
  • CPBI 1.62
  • Revenue
  • CTSO $35,332,238.00
  • CPBI $18,546,000.00
  • Revenue This Year
  • CTSO $18.34
  • CPBI N/A
  • Revenue Next Year
  • CTSO $19.82
  • CPBI N/A
  • P/E Ratio
  • CTSO N/A
  • CPBI $9.31
  • Revenue Growth
  • CTSO 15.37
  • CPBI 13.73
  • 52 Week Low
  • CTSO $0.70
  • CPBI $9.99
  • 52 Week High
  • CTSO $1.61
  • CPBI $15.50
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 67.21
  • CPBI 60.83
  • Support Level
  • CTSO $1.03
  • CPBI $14.85
  • Resistance Level
  • CTSO $1.29
  • CPBI $14.99
  • Average True Range (ATR)
  • CTSO 0.09
  • CPBI 0.09
  • MACD
  • CTSO 0.02
  • CPBI 0.04
  • Stochastic Oscillator
  • CTSO 75.45
  • CPBI 100.00

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.

Share on Social Networks: